Insurance Cuts Off Weight-Loss Drugs, Patients Scramble

Insurance coverage for GLP-1 obesity drugs like Wegovy and Zepbound is declining, forcing patients to pay high out-of-pocket costs or switch medications. Many face restrictive policies, leaving them to navigate financial and medical uncertainty alone.